Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,651 | 11,448 | 12,918 | 14,066 | 15,572 |
| Other current assets | 0 | 0 | 0 | 0 | 37 |
| TOTAL | $9,931 | $11,553 | $13,150 | $14,416 | $15,947 |
| Non-Current Assets | |||||
| PPE Net | 8,291 | 8,418 | 8,557 | 8,694 | 8,805 |
| Intangibles | 336 | 338 | 340 | 342 | 344 |
| Other Non-Current Assets | 19 | 27 | 36 | 43 | 49 |
| TOTAL | $8,646 | $8,782 | $8,933 | $9,079 | $9,198 |
| Total Assets | $18,577 | $20,335 | $22,082 | $23,495 | $25,145 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 24 | 95 | 165 |
| Accounts payable and accrued liabilities | 307 | 39 | 471 | 272 | 197 |
| Accrued Expenses | 42 | 52 | 24 | 46 | 25 |
| TOTAL | $349 | $465 | $518 | $413 | $387 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $349 | $465 | $518 | $413 | $387 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,666 | 11,635 | 11,610 | 11,592 | 11,554 |
| Common Shares | 12 | 12 | 12 | 0 | 12 |
| Retained earnings | -127,511 | -125,808 | -124,063 | -122,492 | -120,712 |
| Other shareholders' equity | 1 | 1 | 1 | 0 | 1 |
| TOTAL | $18,228 | $19,870 | $21,564 | $23,082 | $24,758 |
| Total Liabilities And Equity | $18,577 | $20,335 | $22,082 | $23,495 | $25,145 |